Optimizing tuberculosis case detection through a novel diagnostic device placement model: The case of Uganda

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Pho, Mari T ^a   Deo, Sarang ^b   Palamountain, Kara M ^c   Joloba, Moses Lutaakome ^d   Bajunirwe, Francis ^e   Katamba, Achilles ^d  

^a UNIVERSITY OF CHICAGO   (United States)

^b INDIAN SCHOOL OF BUSINESS   (India)

^c NORTHWESTERN UNIVERSITY   (United States)

^d MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^e MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; RIFAMPICIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALGORITHM; ARTICLE; CASE STUDY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EPIDEMIOLOGICAL DATA; HEALTH CARE COST; HEALTH CENTER; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MICROSCOPY; MULTIDRUG RESISTANT TUBERCULOSIS; NATIONAL HEALTH SERVICE; OUTCOME ASSESSMENT; PREVALENCE; RESPIRATORY DIAGNOSTIC DEVICE; SENSITIVITY AND SPECIFICITY; SPUTUM SMEAR; STATISTICAL ANALYSIS; TUBERCULOSIS; UGANDA; XPERT DEVICE; COINFECTION; COST BENEFIT ANALYSIS; DIAGNOSTIC EQUIPMENT; ECONOMICS; HEALTH CARE FACILITY; HIV INFECTIONS; NEEDS ASSESSMENT; TUBERCULOSIS, PULMONARY;

COINFECTION; COST-BENEFIT ANALYSIS; DIAGNOSTIC EQUIPMENT; HEALTH FACILITIES; HIV INFECTIONS; HUMANS; NEEDS ASSESSMENT; PREVALENCE; TUBERCULOSIS, PULMONARY; UGANDA;

EID: 84926513068     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122574     Document Type: Article

References (23)

1. WHO. Global Tuberculosis Report. Geneva: 2013. Available: http://apps.who.int/iris/bitstream/10665/ 91355/1/9789241564656-eng.pdf.
2. Evans CA. GeneXpert-a game-changer for tuberculosis control? PLoS Med. 2011; 8(7):e1001064. doi: 10.1371/journal.pmed.1001064 PMID: 21814497
3. WHO. WHO endorses new rapid tuberculosis test. London. News release. 2010 December 8, 2010. Available: http://www.who.int/mediacentre/news/releases/2010/tb-test-20101208/en/.
4. Abimbola TO, Marston BJ, Date AA, Blandford JM, Sangrujee N, Wiktor SZ. Cost-effectiveness of tuberculosis diagnostic strategies to reduce early mortality among persons with advanced HIV infection initiating antiretroviral therapy. J Acquir Immune Defic Syndr. 2012; 60(1):e1-7. doi: 10.1097/QAI. 0b013e318246538f PMID: 22240465
5. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet. 2011; 377(9776):1495-505. doi: 10. 1016/S0140-6736(11)60438-8 PMID: 21507477
6. Dorman SE, Chihota VN, Lewis JJ, Shah M, Clark D, Grant AD, et al. Performance characteristics of the Cepheid Xpert MTB/RIF test in a tuberculosis prevalence survey. PLoS One. 2012; 7(8):e43307. doi: 10.1371/journal.pone.0043307 PMID: 22905254
7. Lawn SD, Brooks SV, Kranzer K, Nicol MP, Whitelaw A, Vogt M, et al. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study. PLoS Med. 2011; 8(7):e1001067. doi: 10.1371/journal.pmed.1001067 PMID: 21818180
8. Vassall A, van Kampen S, Sohn H, Michael JS, John KR, den Boon S, et al. Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis. PLoS Med. 2011; 8(11):e1001120. doi: 10.1371/journal.pmed.1001120 PMID: 22087078
9. Pai NP, Vadnais C, Denkinger C, Engel N, Pai M. Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low- and middle-income countries. PLoS Med. 2012; 9(9):e1001306. doi: 10.1371/journal.pmed.1001306 PMID: 22973183
10. Pai M, Palamountain KM. New tuberculosis technologies: challenges for retooling and scale-up. Int J Tuberc Lung Dis. 2012; 16(10):1281-90. doi: 10.5588/ijtld.12.0391 PMID: 23107630
11. Programme NTaLC. Draft: Planning & implementation of Xpert MTB/RIF test for detection of tuberculosis. Uganda: 2012.
12. Laboratory NTR. Uganda TB laboratory nework sputum smear microscopy workload data. Kampala, Uganda: 2011.
13. Laboratory NTR. Uganda TB laboratory network external quality assurance data. Kampala, Uganda: 2011.
14. STD/AIDS Control Programme MoH. Status of antiretroviral therapy services in Uganda for 2011. Kampala, Uganda: 2011.
15. Lukoye D, Adatu F, Musisi K, Kasule GW, Were W, Odeke R, et al. Anti-tuberculosis drug resistance among new and previously treated sputum smear-positive tuberculosis patients in Uganda: results of the first national survey. PLoS One. 2013; 8(8):e70763. doi: 10.1371/journal.pone.0070763 PMID: 23936467
16. Stevens W. GeneXpert implementation in South Africa public sector: One year later. lessons learnt 4th Annual WHO/GLI Meeting2012 [cited 2013 September 26]. Available: http://www.stoptb.org/wg/gli/ assets/html/day%203/Stevens%20-%20South%20Africa.pdf.
17. Gane EJ SC, Hyland RH, et al. ELECTRON: once daily PSI-7977 plus RBV in HCV GT1/2/3. 47th Annual Meeting of the European Association for the Study of the Liver2012.
18. Khan MS, Khan S, Godfrey-Faussett P. Default during TB diagnosis: quantifying the problem. Trop Med Int Health. 2009; 14(12):1437-41. doi: 10.1111/j.1365-3156.2009.02406.x PMID: 19843298
19. Cohen G DP, Noubary F, Cloete C, Nixon K, Parker G, Bassett I. Diagnostic delays associated with Xpert MTB/RIF assay in a centralized laboratory for pulmonary TB among HIV+ adults: South Africa. 2013.
20. Foulds J, O'Brien R. New tools for the diagnosis of tuberculosis: the perspective of developing countries. Int J Tuberc Lung Dis. 1998; 2(10):778-83. PMID: 9783521
21. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance. Expert Rev Mol Diagn. 2006; 6(3):423-32. PMID: 16706744
22. Perkins MD. New diagnostic tools for tuberculosis. Int J Tuberc Lung Dis. 2000; 4(12 Suppl 2):S182-8.PMID: 11144551
23. Mugambi ML, Deo S, Kekitiinwa A, Kiyaga C, Singer ME. Do diagnosis delays impact receipt of test results? Evidence from the HIV early infant diagnosis program in Uganda. PLoS One. 2013; 8(11): e78891. doi: 10.1371/journal.pone.0078891 PMID: 24282502